Academic · Private company
Alliance for Clinical Trials in Oncology
Track this companyFree. Adds Alliance for Clinical Trials in Oncology to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After TreatmentPHASE2 · RECRUITING · started Oct 14, 2026ClinicalTrials.gov NCT07293247 · fetched Nov 12, 2026
- Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain CancerPHASE3 · RECRUITING · started Jun 24, 2026ClinicalTrials.gov NCT07215910 · fetched Nov 12, 2026
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLLPHASE3 · RECRUITING · started Apr 30, 2026ClinicalTrials.gov NCT07321652 · fetched Nov 12, 2026
- Family Communications After Genetic TestingNA · RECRUITING · started Apr 6, 2026ClinicalTrials.gov NCT07143487 · fetched Nov 12, 2026
- Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialPHASE3 · RECRUITING · started Mar 31, 2026ClinicalTrials.gov NCT07200830 · fetched Nov 12, 2026
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysNA · RECRUITING · started Feb 13, 2026ClinicalTrials.gov NCT07283939 · fetched Nov 12, 2026
- Distance-Based Exercise to Preserve Function and Prevent DisabilityNA · RECRUITING · started Feb 11, 2026ClinicalTrials.gov NCT07059884 · fetched Nov 12, 2026
- Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With CancerNA · RECRUITING · started Dec 10, 2025ClinicalTrials.gov NCT07091617 · fetched Nov 12, 2026
- Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialPHASE3 · RECRUITING · started Dec 1, 2025ClinicalTrials.gov NCT06931340 · fetched Nov 12, 2026
- High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerPHASE3 · RECRUITING · started Jun 5, 2025ClinicalTrials.gov NCT06992427 · fetched Nov 12, 2026
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney CancerPHASE3 · RECRUITING · started Mar 14, 2025ClinicalTrials.gov NCT06661720 · fetched Nov 12, 2026
- Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialPHASE2 · RECRUITING · started Feb 6, 2025ClinicalTrials.gov NCT06632977 · fetched Nov 12, 2026
- Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell LymphomaPHASE3 · RECRUITING · started Oct 20, 2023ClinicalTrials.gov NCT05976763 · fetched Nov 12, 2026
- Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur TrialPHASE2 · RECRUITING · started Oct 9, 2023ClinicalTrials.gov NCT05673148 · fetched Nov 12, 2026
- Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated LiposarcomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 7, 2023ClinicalTrials.gov NCT05694871 · fetched Nov 12, 2026
- Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 16, 2023ClinicalTrials.gov NCT05247905 · fetched Nov 12, 2026
- mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaPHASE3 · RECRUITING · started Jan 31, 2023ClinicalTrials.gov NCT05677490 · fetched Nov 12, 2026
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRECRUITING · started Aug 18, 2022ClinicalTrials.gov NCT05334069 · fetched Nov 12, 2026
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based ProgramPHASE3 · RECRUITING · started Apr 1, 2022ClinicalTrials.gov NCT05008848 · fetched Nov 12, 2026
- Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaPHASE2 · RECRUITING · started Oct 8, 2021ClinicalTrials.gov NCT04803201 · fetched Nov 12, 2026
- Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal TherapyPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 15, 2021ClinicalTrials.gov NCT04379570 · fetched Nov 12, 2026
- Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side EffectsRECRUITING · started Mar 12, 2020ClinicalTrials.gov NCT04242095 · fetched Nov 12, 2026
- Genetic Testing in Guiding Treatment for Patients With Brain MetastasesPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 17, 2019ClinicalTrials.gov NCT03994796 · fetched Nov 12, 2026
- Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaPHASE3 · RECRUITING · started Sep 20, 2017ClinicalTrials.gov NCT03150693 · fetched Nov 12, 2026
- Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasPHASE2 · RECRUITING · started Sep 28, 2015ClinicalTrials.gov NCT02523014 · fetched Nov 12, 2026